FDA letter monthly archive

FDA Letters Issued in September 2020

Name: FDA Letters Issued in September 2020
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued in September 2020. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Mallinckrodt Hospital Products IP Limited (Sep 11, 2020)
FDA's complete response letter contains source-text evidence related to Clinical efficacy and substantial evidence, Labeling, packaging, and proprietary name, Safety and adverse events. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedSep 11, 2020
US FDA• TERLIVAZ

Complete Response Letter Mallinckrodt Hospital Products IP Limited (Sep 11, 2020)